Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-30
DOI
10.1038/s41416-023-02474-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copula graphic estimation of the survival function with dependent censoring and its application to analysis of pancreatic cancer clinical trial
- (2023) Jung Hyun Jo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer
- (2023) Anna Bianchi et al. Cancer Discovery
- Telomerase inhibition regulates EMT mechanism in breast cancer stem cells
- (2020) Alican Kusoglu et al. GENE
- α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer
- (2020) Qiang Chi et al. Cancer Management and Research
- Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia–mesenchymal transition during pancreatic carcinogenesis
- (2019) Ningning Niu et al. GUT
- NRG1 Fusions in KRAS Wild-type Pancreatic Cancer
- (2018) Christoph Heining et al. Cancer Discovery
- Telomerase based anticancer immunotherapy and vaccines approaches
- (2017) Chahal Kailashiya et al. VACCINE
- Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer
- (2017) Gang Wang et al. Cancer Biomarkers
- Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer
- (2016) Beibei Xin et al. PANCREATOLOGY
- Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-1α-VEGF signaling axis
- (2014) Bu-Kyung Kim et al. BIOMATERIALS
- Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies
- (2014) R Roy et al. BRITISH JOURNAL OF CANCER
- Impact of Informative Censoring on the Kaplan-Meier Estimate of Progression-Free Survival in Phase II Clinical Trials
- (2014) Federico Campigotto et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism
- (2014) Jing-Jing Zhang et al. Molecular Cancer
- E-cadherin interactome complexity and robustness resolved by quantitative proteomics
- (2014) Z. Guo et al. Science Signaling
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generalized copula-graphic estimator
- (2013) Jacobo de Uña-Álvarez et al. TEST
- Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?
- (2012) Mothaffar Rimawi et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells
- (2012) Z Liu et al. ONCOGENE
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma
- (2011) J S Liles et al. BRITISH JOURNAL OF CANCER
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin-Like Growth Factor Axis Gene Polymorphisms and Clinical Outcomes in Pancreatic Cancer
- (2010) Xiaoqun Dong et al. GASTROENTEROLOGY
- A copula-based mixed Poisson model for bivariate recurrent events under event-dependent censoring
- (2010) Richard J. Cook et al. STATISTICS IN MEDICINE
- Cancer vaccination with telomerase peptide GV1001
- (2009) Jon Amund Kyte EXPERT OPINION ON INVESTIGATIONAL DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now